Evidence based use of antibiotics in epidemic keratoconjunctivitis to prevent development of microbial resistance

Aim: It was thought that resistance acquired during treatment of systemic diseases can lead to resistant bacteria in eye infections. However, evidences are showing emergence of bacterial resistance owing to prior topical antibiotic usage. In the current study, we intended to promote evidence-based u...

Full description

Saved in:
Bibliographic Details
Main Authors: Shalini Kumari, Imsensenba Longkumer, Mamta Sharma, Shashank Tripathi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:https://journals.lww.com/10.4103/jfmpc.jfmpc_1123_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823858101986525184
author Shalini Kumari
Imsensenba Longkumer
Mamta Sharma
Shashank Tripathi
author_facet Shalini Kumari
Imsensenba Longkumer
Mamta Sharma
Shashank Tripathi
author_sort Shalini Kumari
collection DOAJ
description Aim: It was thought that resistance acquired during treatment of systemic diseases can lead to resistant bacteria in eye infections. However, evidences are showing emergence of bacterial resistance owing to prior topical antibiotic usage. In the current study, we intended to promote evidence-based usage of antibiotics during outbreak of epidemic keratoconjunctivitis. Methods: A descriptive study was designed. First 50 patients who visited the outpatient department of ophthalmology with signs and symptoms of EKC during the outbreak in the months of July-August, 2023 in a tertiary hospital in northern India were included in the study. Prior usage of topical antibiotics during this epidemic outbreak was the exclusion criteria. Conjunctival swabs were taken and subjected to Gram staining and Culture and sensitivity, for any bacterial infection. Results: Only two slides of gram stain showed gram-positive cocci. These two samples were positive for Methicillin resistant Staphylococcs Aureus (MRSA). Rest of the 48 samples were negative for any bacterial growth. P value for no growth in bacterial cultures was <0.05, which is significant. Conclusions: Our study suggests restrain from overusage of topical antibiotics in outbreaks of EKC until microbiological outcomes suggest otherwise. In view of presence of MRSA in neo-natal sample, and its known serious complications, we suggest prophylactic use of topical antibiotic and its modifications once reports of culture and sensitivity are available.
format Article
id doaj-art-2014cf5ebaaa40a2a555bf1f718c8ae9
institution Kabale University
issn 2249-4863
2278-7135
language English
publishDate 2025-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Family Medicine and Primary Care
spelling doaj-art-2014cf5ebaaa40a2a555bf1f718c8ae92025-02-11T13:58:03ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632278-71352025-01-0114141241810.4103/jfmpc.jfmpc_1123_24Evidence based use of antibiotics in epidemic keratoconjunctivitis to prevent development of microbial resistanceShalini KumariImsensenba LongkumerMamta SharmaShashank TripathiAim: It was thought that resistance acquired during treatment of systemic diseases can lead to resistant bacteria in eye infections. However, evidences are showing emergence of bacterial resistance owing to prior topical antibiotic usage. In the current study, we intended to promote evidence-based usage of antibiotics during outbreak of epidemic keratoconjunctivitis. Methods: A descriptive study was designed. First 50 patients who visited the outpatient department of ophthalmology with signs and symptoms of EKC during the outbreak in the months of July-August, 2023 in a tertiary hospital in northern India were included in the study. Prior usage of topical antibiotics during this epidemic outbreak was the exclusion criteria. Conjunctival swabs were taken and subjected to Gram staining and Culture and sensitivity, for any bacterial infection. Results: Only two slides of gram stain showed gram-positive cocci. These two samples were positive for Methicillin resistant Staphylococcs Aureus (MRSA). Rest of the 48 samples were negative for any bacterial growth. P value for no growth in bacterial cultures was <0.05, which is significant. Conclusions: Our study suggests restrain from overusage of topical antibiotics in outbreaks of EKC until microbiological outcomes suggest otherwise. In view of presence of MRSA in neo-natal sample, and its known serious complications, we suggest prophylactic use of topical antibiotic and its modifications once reports of culture and sensitivity are available.https://journals.lww.com/10.4103/jfmpc.jfmpc_1123_24antibiotic resistancebacteriaepidemic keratoconjunctivitisfluoroquinolonesocular infections
spellingShingle Shalini Kumari
Imsensenba Longkumer
Mamta Sharma
Shashank Tripathi
Evidence based use of antibiotics in epidemic keratoconjunctivitis to prevent development of microbial resistance
Journal of Family Medicine and Primary Care
antibiotic resistance
bacteria
epidemic keratoconjunctivitis
fluoroquinolones
ocular infections
title Evidence based use of antibiotics in epidemic keratoconjunctivitis to prevent development of microbial resistance
title_full Evidence based use of antibiotics in epidemic keratoconjunctivitis to prevent development of microbial resistance
title_fullStr Evidence based use of antibiotics in epidemic keratoconjunctivitis to prevent development of microbial resistance
title_full_unstemmed Evidence based use of antibiotics in epidemic keratoconjunctivitis to prevent development of microbial resistance
title_short Evidence based use of antibiotics in epidemic keratoconjunctivitis to prevent development of microbial resistance
title_sort evidence based use of antibiotics in epidemic keratoconjunctivitis to prevent development of microbial resistance
topic antibiotic resistance
bacteria
epidemic keratoconjunctivitis
fluoroquinolones
ocular infections
url https://journals.lww.com/10.4103/jfmpc.jfmpc_1123_24
work_keys_str_mv AT shalinikumari evidencebaseduseofantibioticsinepidemickeratoconjunctivitistopreventdevelopmentofmicrobialresistance
AT imsensenbalongkumer evidencebaseduseofantibioticsinepidemickeratoconjunctivitistopreventdevelopmentofmicrobialresistance
AT mamtasharma evidencebaseduseofantibioticsinepidemickeratoconjunctivitistopreventdevelopmentofmicrobialresistance
AT shashanktripathi evidencebaseduseofantibioticsinepidemickeratoconjunctivitistopreventdevelopmentofmicrobialresistance